Downregulation of LncRNA GAS5 causes trastuzumab resistance in breast cancer
Therapeutic resistance to trastuzumab caused by dysregulation of long noncoding RNAs (lncRNAs) is a major obstacle to clinical management of HER2-positive breast cancer. To investigate which lncRNAs contribute to trastuzumab resistance, we screened a microarray of lncRNAs involved in the malignant p...
Main Authors: | Li, Wentong, Zhai, Limin, Wang, Hui, Liu, Chuanliang, Zhang, Jinbao, Chen, Weijuan, Wei, Qun |
---|---|
Format: | Online |
Language: | English |
Published: |
Impact Journals LLC
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053687/ |
Similar Items
-
LncRNA-ATB promotes trastuzumab resistance and invasion-metastasis cascade in breast cancer
by: Shi, Sheng-Jia, et al.
Published: (2015) -
Downregulation of lncRNA-HOXA11-AS modulates proliferation and stemness in Glioma cells
by: Zuoxin Zhang, et al.
Published: (2017-09-01) -
Downregulation of lncRNA ANRIL suppresses growth and metastasis in human osteosarcoma cells
by: Guan H, et al.
Published: (2018-08-01) -
LncRBase: An Enriched Resource for lncRNA Information
by: Chakraborty, Sohini, et al.
Published: (2014) -
Construction and analysis of lncRNA-lncRNA synergistic networks to reveal clinically relevant lncRNAs in cancer
by: Li, Yongsheng, et al.
Published: (2015)